Bilateral axillo-breast approach robotic thyroidectomy (BABA-RT) versus transoral robotic thyroidectomy (TORT): a systematic review and meta-analysis

被引:0
作者
Ebraheem Albazee
Ahmed Abdelaziz
Reham Alabdulhadi
Danah Ibrahim Alkandari
Aysha Abduljabbar
Sara Sulaiman
Mohammad Alnifise
Jasem Ameen
Houda Magzoub
Karim Alomar
Shaima Ali Maghdi
Ahmed Abu-Zaid
机构
[1] Kuwait Institute for Medical Specializations (KIMS),Faculty of Medicine
[2] Al-Azhar University,College of Medicine and Medical Science
[3] Arabian Gulf University,Faculty of Medicine
[4] The Hashemite University,College of Arts and Science
[5] Touro College of Osteopathic Medicine,Department of Surgery
[6] University of Saskatchewan,College of Medicine
[7] King Fahad Central Hospital,College of Graduate Health Sciences
[8] Alfaisal University,undefined
[9] University of Tennessee Health Science Center,undefined
来源
Updates in Surgery | 2023年 / 75卷
关键词
Thyroidectomy; TORT; BABA-RT; Minimally invasive surgery; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study is to conduct a systematic review and meta-analysis of all comparative studies that evaluated the surgical outcomes between bilateral axillo-breast approach-robotic thyroidectomy (BABA-RT) and transoral robotic thyroidectomy (TORT). The Cochrane Central Register of Controlled Trials, PubMed, Scopus, and Web of Science databases were screened until July 2022. The Risk of Bias in Non-Randomized Studies for Interventions (ROBINS-I) tool was used to evaluate study quality. The data were summarized as mean difference (MD) or risk ratio (RR) with 95% confidence interval (CI) in a fixed-effects or random-effects model. Five comparative observational studies met the inclusion criteria comprising 923 patients (TORT = 408 and BABA-RT = 515). The study quality varied and included low (n = 4) and moderate (n = 1) risk of bias. There was no significant difference between both groups regarding the mean operative time (MD = 19.98 min, 95% CI [−11.33, 51.28], p = 0.21), mean hospital stay (MD = −0.14 days, 95% CI [−0.66, 0.38], p = 0.60), mean number of retrieved lymph nodes (MD = 0.42, 95% CI [−0.16, 0.99], p = 0.16), and rate of recurrent laryngeal nerve injury (RR = 0.39, 95% CI [0.13, 1.19], p = 0.10). However, the TORT group had significantly reduced mean postoperative pain score (MD = −0.39, 95% CI [−0.51, −0.26], p < 0.001) and lower rate of hypocalcemia (RR = 0.08, 95% CI [0.02, 0.26], p < 0.001) than the BABA-RT group. TORT and BABA-RT have comparable surgical outcomes. Both methods are largely safe and effective when patients are carefully chosen. However, TORT appears to offer better results regarding postoperative pain and hypocalcemia. Further clinical trials with extended follow-up periods are needed to confirm our findings.
引用
收藏
页码:1277 / 1287
页数:10
相关论文
共 144 条
[1]  
Wang J(2020)Thyroid cancer: incidence and mortality trends in China, 2005–2015 Endocrine 68 163-173
[2]  
Yu F(2018)A comparison study of the transoral and bilateral axillo-breast approaches in robotic thyroidectomy J Surg Oncol 118 381-387
[3]  
Shang Y(2017)Transoral thyroidectomy: why is it needed? Gland Surg 6 272-1039
[4]  
Ping Z(2020)Robotic thyroidectomy: past, future, and current perspectives Otolaryngol Clin North Am 53 1031-105
[5]  
Liu L(2021)Health-related quality of life after transoral robotic thyroidectomy in papillary thyroid carcinoma Surgery 170 99-800
[6]  
Kim WW(2019)Transoral robotic thyroidectomy versus conventional open thyroidectomy: comparative analysis of surgical outcomes in thyroid malignancies J Laparoendosc Adv Surg Tech 29 796-9
[7]  
Lee J(2019)Indications, benefits and risks of transoral thyroidectomy Best Pract Res Clin Endocrinol Metab 33 1-892
[8]  
Jung JH(2022)A comparative study of two robotic thyroidectomy procedures: transoral vestibular versus bilateral axillary-breast approach BMC Surg 22 886-232
[9]  
Park HY(2018)Comparative analysis of 2 robotic thyroidectomy procedures: transoral versus bilateral axillo-breast approach Head Neck 40 226-245
[10]  
Tufano RP(2014)Can robotic thyroidectomy be performed safely in thyroid carcinoma patients? Endocrinol Metab 29 239-1240